Medifast Inc. (MED)
undefined
undefined%
At close: undefined
19.16
-0.03%
After-hours Dec 13, 2024, 07:00 PM EST

Medifast Statistics

Share Statistics

Medifast has 10.94M shares outstanding. The number of shares has increased by 0.41% in one year.

Shares Outstanding 10.94M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 10.61M
Failed to Deliver (FTD) Shares 30
FTD / Avg. Volume 0.02%

Short Selling Information

The latest short interest is 1.65M, so 15.12% of the outstanding shares have been sold short.

Short Interest 1.65M
Short % of Shares Out 15.12%
Short % of Float 15.58%
Short Ratio (days to cover) 11.03

Valuation Ratios

The PE ratio is 7.36 and the forward PE ratio is 64.7.

PE Ratio 7.36
Forward PE 64.7
PS Ratio 0.68
Forward PS 0.4
PB Ratio 3.63
P/FCF Ratio 5.18
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Medifast Inc. has an Enterprise Value (EV) of 659.19M.

EV / Earnings 6.63
EV / Sales 0.61
EV / EBITDA 4.73
EV / EBIT 5.22
EV / FCF 4.67

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.03.

Current Ratio 2.43
Quick Ratio 1.84
Debt / Equity 0.03
Total Debt / Capitalization 2.84
Cash Flow / Debt 25.09
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is 0.49% and return on capital (ROIC) is 43.66%.

Return on Equity (ROE) 0.49%
Return on Assets (ROA) 0.32%
Return on Capital (ROIC) 43.66%
Revenue Per Employee 1.69M
Profits Per Employee 156.81K
Employee Count 634
Asset Turnover 3.46
Inventory Turnover 5.43

Taxes

Income Tax 29.38M
Effective Tax Rate 0.23

Stock Price Statistics

The stock price has increased by -71.93% in the last 52 weeks. The beta is 1.16, so Medifast 's price volatility has been higher than the market average.

Beta 1.16
52-Week Price Change -71.93%
50-Day Moving Average 18.75
200-Day Moving Average 23.35
Relative Strength Index (RSI) 55.06
Average Volume (20 Days) 195.72K

Income Statement

In the last 12 months, Medifast had revenue of $1.07B and earned $99.42M in profits. Earnings per share was $9.13.

Revenue 1.07B
Gross Profit 775.85M
Operating Income 126.40M
Net Income 99.42M
EBITDA 139.51M
EBIT 126.40M
Earnings Per Share (EPS) 9.13
Full Income Statement

Balance Sheet

The company has $94.44M in cash and $22.01M in debt, giving a net cash position of $72.43M.

Cash & Cash Equivalents 94.44M
Total Debt 22.01M
Net Cash 72.43M
Retained Earnings 174.65M
Total Assets 291.24M
Working Capital 152.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $147.66M and capital expenditures -$6.48M, giving a free cash flow of $141.17M.

Operating Cash Flow 147.66M
Capital Expenditures -6.48M
Free Cash Flow 141.17M
FCF Per Share 12.97
Full Cash Flow Statement

Margins

Gross margin is 72.37%, with operating and profit margins of 11.79% and 9.27%.

Gross Margin 72.37%
Operating Margin 11.79%
Pretax Margin 12.01%
Profit Margin 9.27%
EBITDA Margin 13.01%
EBIT Margin 11.79%
FCF Margin 13.17%

Dividends & Yields

MED pays an annual dividend of $4.95, which amounts to a dividend yield of 24.57%.

Dividend Per Share $4.95
Dividend Yield 24.57%
Dividend Growth (YoY) 0%
Payout Ratio 738.81%
Earnings Yield 47.65%
FCF Yield 67.35%
Dividend Details

Analyst Forecast

The average price target for MED is $17, which is -11.3% lower than the current price. The consensus rating is "Hold".

Price Target $17
Price Target Difference -11.3%
Analyst Consensus Hold
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score 5.49
Piotroski F-Score 7